Abstract
purpose. To determine the probability of future glaucomatous visual field (VF) progression with clinical and perimetric data.
methods. One hundred sixty-one eyes of patients (161) enrolled in the Advanced Glaucoma Intervention Study (AGIS) with ≥8 years of follow-up and a baseline VF score ≤16 were selected. VF progression at 8 years was determined with point-wise linear regression (PLR) analysis, using a two-omitting algorithm. The course of VF series over the first 4 years of follow-up was quantified by an index, the sum of slopes, which is the sum of all slopes of VF thresholds with P < 0.05 when PLR was performed on the 4-year data. The following parameters were included in a logistic regression model to predict 8-year outcomes from the first 4 years of follow-up: intervention sequence, age, AGIS VF score, mean IOP, IOP fluctuation, and sum of slopes.
results. Sixty-four (40%) eyes progressed after 8 years as determined by PLR analysis. Two parameters were predictive of subsequent VF progression, as identified at 8 years (predictive power: 76%): more negative sum of slopes (i.e., faster or more extensive deterioration; P < 0.001) and older age at 4 years (P = 0.049). When sum of slopes alone was used to predict outcomes at 8 years, the predictive power was the same.
conclusions. The VF sum of slopes can be used to estimate the probability of subsequent VF worsening with reasonable, clinically useful accuracy. This probability may be combined with other clinical information for more effective clinical predictions and treatment decisions.
Recent analyses of data from the Advanced Glaucoma Intervention Study (AGIS)
1 and previous AGIS reports
2 3 have shown the most important predictors for visual field (VF) progression to be older age at the time of first glaucoma intervention, greater intraocular pressure (IOP) fluctuation, higher mean IOP, and lower baseline AGIS VF score. Length of follow-up and number of glaucoma interventions have also been found to be less important, but significant, risk factors for glaucomatous VF progression. Clinicians often have available VF series obtained during earlier follow-up and depend on both kinds of data to make an informed decision about glaucoma treatment in a given patient. No study has been undertaken to investigate whether and how combining these different types of clinical information would be helpful for predicting the subsequent course of glaucoma in an individual patient.
The purpose of this study was to investigate whether clinical or perimetric data gathered during follow-up can provide the clinician with a probability estimate for subsequent glaucomatous VF progression.
A computer (with SPSS, ver. 11.5; SPSS Inc., Chicago IL) was used to perform point-wise linear regression analyses. Our methodology is described in detail elsewhere.
6 We used the two-omitting regression algorithm recently described by Gardiner and Crabb
7 for definition of change versus stability at each point at 8 years. In summary, a test location is considered progressing or improving during the follow-up period if the regression slope is statistically and clinically significant (as defined later) in both of the following regression analyses: (1) after omitting the last threshold in a series and (2) after deleting the threshold before last for the same series. This approach has been shown, in simulation experiments, to be more specific than using all the data points for a single regression analysis, and it maintains a sensitivity comparable to other stringent algorithms used for the same purpose, such as two of two
8 or three of four.
9 10 Regression slopes were considered significant if ≥1.00 dB/year or ≤−1.0 dB/year in presence of
P ≤0.01.
For evaluation of VF series after 8 years of follow-up, we used the most clinically rigorous set of criteria explored in the aforementioned investigation
6 : the two point Glaucoma Hemifield Test (GHT) change criterion. According to this criterion, a VF series is designated as changing if two test locations belonging to the same GHT cluster demonstrate change in the same direction. This set of criteria was found to be the most conservative among various PLR approaches. VF outcomes from PLR at 8 years were classified as progressing or nonprogressing. Improving and stable eyes were categorized together as nonprogressing.
As a comparison, we also used the AGIS criteria as an alternative outcome measure for VF progression at 8 years. VF progression according to AGIS criteria was defined as the first occurrence in an eye, at three consecutive 6-month visits, of a worsening in VF defect score of 4 or more from the baseline value. Changes in AGIS VF defect score were measured from preintervention reference values.
To summarize VF data over the first 4 years of follow-up, we defined a new index based on PLR that we called sum of slopes at 4 years. A single point-wise linear regression analysis was performed on all VF thresholds gathered during the first 4 years of follow-up. The sum of slopes was calculated as the arithmetic sum of all regression slopes with *P < 0.05.
Multivariate logistic regression was used to predict the 8-year VF outcomes from 4-year perimetric and clinical data. Preoperative and postoperative factors that were associated with VF progression in univariate analyses (χ2 test, unpaired t-test, or Mann-Whitney test, depending on the type of data) at P ≤ 0.20 were included in the final model. In addition, we included all clinically relevant variables that might predict or confound detection of VF progression. The following risk factors or potentially confounding factors were entered into the final logistic model for prediction of VF worsening at 8 years: intervention sequence, age at 4-year follow-up, mean IOP and IOP fluctuation during the first 4 years of follow-up, AGIS VF score, and sum of slopes at 4 years. Standard deviation of the IOP at all visits after the initial surgery was used as a measure of IOP fluctuation.
Multivariate logistic regression is usually used to predict a binary variable or group assignment with a defined cutoff point. The resultant values for the dependent variable in the logistic regression equation can vary from 0 to 1. Ordinarily, values below 0.5 or another selected cutoff point are assigned to one group and higher values to the other group.
Alternatively, these probabilities can be interpreted as an estimate of probability for occurrence of the dependent variable (here VF progression at 8 years). Once predictive factors have been determined and a valid regression equation is established, the probability estimates may be used to assist informed decision making about further management of glaucoma after an initial period of follow-up.
The binary results of logistic regression or the probability of progression at 8 years can therefore be estimated for each eye using the logistic regression equation after inclusion of predictive factors for VF progression at 8 years:
\[P_{x}\ {=}\ 1/1\ {+}\ e^{{-}(b_{0}{+}b_{1}X_{1}{+}b_{2}X_{2}{+}{\ldots}{+}b_{n}X_{n})}\]
where
P x is the probability of occurrence of an outcome (VF progression here),
e is the root of the natural logarithm,
b 0 is the intercept,
b 1… n is the regression coefficient(s) for independent variable(s), and
X 1… n is independent variable(s) included in the logistic regression equation.
The cutoff point for classification by logistic regression was set at 0.50 in this study. Variables with P ≤ 0.05 or less were considered statistically significant.
We investigated the possibility of predicting the future course of treated glaucoma with clinical and VF data gathered during earlier follow-up of patients enrolled in AGIS. We applied strict PLR criteria at 8 years to define VF outcomes. Then, the first 4 years of data were used to predict the VF outcomes at 8 years. We found that the “sum of slopes” derived from point-wise linear regression analysis on VFs performed during the first 4 years after recruitment of patients was the strongest predictor of VF status at 8 years. Although older age during the first 4 years of follow-up was also significantly associated with VF status at 8 years, the influence of the sum of slopes far exceeded that of age.
In a preliminary study, McNaught et al.
11 compared different curve-fitting models for predicting individual VF thresholds over time. They found that PLR was the best model for prediction of threshold sensitivity at individual test locations when the first five VFs were used to predict the threshold sensitivity at selected test locations on the 15th VF examination performed during follow-up of patients with normal-tension glaucoma. Our study is different in that we addressed the problem of predicting the course of the entire VF series at 8 years using information available during the first 4 years of follow-up, including clinical and perimetric data. The AGIS database was considered an appropriate database for this investigation, because a large proportion of patients enrolled in AGIS were followed for >8 years. The AGIS patients also had regular VF examinations every 6 months during the course of the study, making this database an excellent medium for application of PLR. However, it must be emphasized that AGIS patients represent a subgroup of patients with advanced glaucoma who are no longer controlled on medical treatment. Hence, the rate and pattern of glaucoma progression is not necessarily generalizable to patients at large with primary open-angle glaucoma. This, though, does not diminish the value of the model presented in this investigation.
The major advantage of using sum of slopes to summarize the course of VFs is that no empiric interim judgment or assumptions regarding progression of VF series is required at 4 years. It also enabled us to summarize the data derived from the VFs as a single number. Given the lack of a gold standard for the detection of VF progression, a given eye may need to be followed for a long time before a definite decision regarding the course of the VF series can be reached. Therefore, use of a summary index, such as sum of slopes, would allow the clinician to calculate a probability for future worsening of glaucoma. Clinicians can then combine this probability estimate with other available clinical information, such as age and indices of IOP control to make a more informed decision regarding continuing care of individual patients.
Figures 2 and 3 show examples of how the probability estimate can replace the binary—yes or no—outcome of the logistic equation. Although based on a cutoff point of 0.5, we expected that the examples would be classified as nonprogressing and progressing, respectively, the probability estimates derived from the same analysis (
P x : 20% and 66%) provide quantitative probabilities that are more meaningful and can be taken into account along with other clinical findings for better clinical decision making.
The sum of slopes can also provide quantitative information regarding the rate of progression, although there is loss of spatial information. When we applied the same PLR criteria for definition of VF progression during the first 4 years of follow-up, the resultant binary findings were not as strongly associated with VF status at 8 years. Point-wise linear regression analysis is the only currently used technique (in addition to Glaucoma Change Probability Analysis of the Humphrey Field Analyzer; Carl Zeiss Meditec) for which commercial software (Progressor; OBF Laboratories UK Ltd., Wiltshire, UK) is available. The sum of slopes index could be easily integrated into software and used clinically.
A previous AGIS report and a recent analysis of the AGIS database with PLR have found that mean IOP and IOP fluctuation, defined as the standard deviation of all IOP measurements after initial surgery, were strong risk factors for predicting VF progression.
1 2 In the present study, neither mean IOP nor IOP fluctuation during the first 4 years of follow-up had predictive value for the VF status at 8 years. We speculate that there may be an inadequate number of IOP measurements during the first 4 years for a robust estimate of mean IOP or IOP fluctuation. These results do not necessarily contradict the findings of the aforementioned studies.
A limitation of PLR is the requirement of a minimum of six to eight fields before the results are meaningful.
12 13 14 Therefore, assuming that VFs are performed every 6 months after the baseline examination, PLR can be applied only after three or more years of follow-up.
We have previously shown that AGIS and PLR criteria agree in two thirds of the eyes in AGIS.
6 Of note, when AGIS criteria were used for definition of VF outcomes at 8 years, the sum of slopes was still the strongest and only significant predictor of subsequent VF change. This confirms the value of sum of slopes for forecasting the subsequent course of VFs.
In conclusion, we have presented evidence that the index sum of slope, derived from point-wise linear regression analysis of VF data obtained during early follow-up of patients with glaucoma is a useful and relevant predictor of the future course of VF series. The probability estimate provided by the logistic regression analysis can be combined with other clinical data to make better-informed decisions regarding continuing care of patients with glaucoma.
Presented at the annual meeting of the Association for Research in Vision and Ophthalmology, Fort Lauderdale, Florida, April 2004; and at the annual meeting of the American Glaucoma Society, Sarasota, Florida, March 2004.
Supported by an unrestricted grant from Research to Prevent Blindness and National Eye Institute Grant R01 EY12738.
Submitted for publication February 24, 2004; revised May 5, 2004; accepted May 12, 2004.
Disclosure:
K. Nouri-Mahdavi, None;
D. Hoffman, None;
D. Gaasterland, None;
J. Caprioli, None
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be marked “
advertisement” in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Corresponding author: Joseph Caprioli, Glaucoma Division, Jules Stein Eye Institute, 100 Stein Plaza, Los Angeles, CA 90095;
caprioli@jsei.ucla.edu.
Table 1. Characteristics of the Study Sample According to Visual Field Outcomes at 8 Years
Table 1. Characteristics of the Study Sample According to Visual Field Outcomes at 8 Years
| Progressing | | Nonprogressing | | |
| No. | % | No. | % | P |
Total | 64 | 39.8 | 97 | 60.2 | |
Eye | | | | | |
Right | 36 | 56.3 | 40 | 41.2 | 0.060 |
Left | 28 | 43.8 | 57 | 58.8 | |
Gender | | | | | |
Male | 29 | 44.4 | 48 | 49.5 | 0.518 |
Female | 35 | 55.6 | 49 | 50.5 | |
Race | | | | | |
Black | 35 | 54.7 | 47 | 48.5 | 0.687 |
White | 28 | 43.8 | 49 | 50.5 | |
Hispanic | 1 | 1.6 | 1 | 1.0 | |
Age after 4 years of follow-up (y) | | | | | |
Mean | | 71 | | 66 | < 0.001* |
SD | | 6.7 | | 10.8 | |
Range | | 49–82 | | 45–85 | |
Intervention sequence | | | | | |
ATT | 32 | 50 | 51 | 52.6 | 0.749 |
TAT | 32 | 50 | 46 | 47.4 | |
Cataract surgery during follow-up | | | | | |
No | 34 | 53.1 | 58 | 59.8 | 0.403 |
Yes | 30 | 46.9 | 39 | 40.2 | |
No. of visual field exams per eye during first 4 years | | | | | |
Mean | | 9.6 | | 9.6 | 0.370 |
SD | | 0.9 | | 1 | |
Range | | 6–11 | | 6–11 | |
Mean IOP during first 4 years (mm Hg) | | | | | |
Mean | | 16.6 | | 15.7 | 0.080 |
SD | | 3 | | 3.4 | |
Range | | 7.2–22.7 | | 6.9–22.3 | |
IOP fluctuation (mm Hg) | | | | | |
Mean | | 3.2 | | 2.8 | 0.190 |
SD | | 1.9 | | 2 | |
Range | | 1.0–12.0 | | 0.7–15.9 | |
AGIS visual field score at 4 years | | | | | |
Mean | | 9.5 | | 7 | 0.001* |
SD | | 4.1 | | 4.5 | |
Range | | 0–16 | | 0–16 | |
Sum of slopes at 4 years (dB/y) | | | | | |
Mean | | −28.7 | | 1.9 | < 0.001, † |
SD | | 38.9 | | 14.5 | |
Range | | −236.9 to +10.4 | | −58.6 to +42.2 | |
Table 2. Results of Logistic Regression
Table 2. Results of Logistic Regression
| P | Odds Ratio | 95% CI for OR | |
| | | Lower | Upper |
Intervention sequence (TAT sequence) | 0.709 | 1.172 | 0.509 | 2.699 |
Age at 4 years of follow-up (y) | 0.049 | 1.048 | 1.000 | 1.097 |
AGIS VF score at 4 years | 0.590 | 1.028 | 0.931 | 1.135 |
Mean IOP during the first 4 years (mm Hg) | 0.246 | 1.083 | 0.947 | 1.238 |
IOP fluctuation during the first 4 years (mm Hg) | 0.966 | 0.995 | 0.803 | 1.233 |
Sum of slopes at 4 years (dB/y) | < 0.001 | 0.918 | 0.886 | 0.951 |
Table 3. Results of Logistic Regression According to Performance of Cataract Surgery with Pointwise Linear Regression Analysis Used to Determine Visual Field Progression
Table 3. Results of Logistic Regression According to Performance of Cataract Surgery with Pointwise Linear Regression Analysis Used to Determine Visual Field Progression
| P | Odds Ratio | 95% CI for OR | |
| | | Lower | Upper |
No cataract extraction | | | | |
Intervention sequence (TAT sequence) | 0.827 | 0.891 | 0.316 | 2.510 |
Age at 4 years of follow-up (years) | 0.040 | 1.068 | 1.003 | 1.138 |
AGIS VF score at 4 years | 0.061 | 1.128 | 0.995 | 1.279 |
Mean IOP during the first 4 years (mm Hg) | 0.740 | 0.971 | 0.819 | 1.152 |
IOP fluctuation during the first 4 years (mm Hg) | 0.540 | 1.115 | 0.786 | 1.582 |
Sum of slopes at 4 years (dB/year) | 0.027 | 0.952 | 0.912 | 0.994 |
Cataract extraction during follow-up | | | | |
Intervention sequence (TAT sequence) | 0.693 | 1.439 | 0.237 | 8.759 |
Age at 4 years of follow-up (years) | 0.371 | 1.046 | 0.947 | 1.156 |
AGIS VF score at 4 years | 0.076 | 0.799 | 0.623 | 1.024 |
Mean IOP during the first 4 years (mm Hg) | 0.362 | 1.170 | 0.834 | 1.641 |
IOP fluctuation during the first 4 years (mm Hg) | 0.542 | 1.108 | 0.797 | 1.540 |
Sum of slopes at 4 years (dB/year) | 0.001 | 0.826 | 0.737 | 0.927 |
The authors thank all the AGIS investigators for their contributions.
Nouri-Mahdavi K, Hoffman D, Coleman AL, et al. Predictive factors for glaucomatous visual field progression in Advanced Glaucoma Intervention Study. Ophthalmology
. 2004;111:1627–1635.
[CrossRef] [PubMed] The Advanced Glaucoma Intervention Study (AGIS). 7. The relationship between control of intraocular pressure and visual field deterioration. The AGIS Investigators. Am J Ophthalmol
. 2000;130:429–440.
[CrossRef] [PubMed] The Advanced Glaucoma Intervention Study (AGIS). 12. Baseline risk factors for sustained loss of visual field and visual acuity in patients with advanced glaucoma. Am J Ophthalmol
. 2002;134:499–512.
[CrossRef] [PubMed] The Advanced Glaucoma Intervention Study (AGIS). 1. Study design and methods and baseline characteristics of study patients. Control Clin Trials
. 1994;15:299–325.
[CrossRef] [PubMed] Advanced Glaucoma Intervention Study. 2. Visual field test scoring and reliability. Ophthalmology
. 1994;101:1445–1455.
[CrossRef] [PubMed]Nouri-Mahdavi K, Coleman AL, Hoffman D, Caprioli J, Gaasterland DE. Pointwise linear regression for evaluation of visual field outcomes and comparison to the AGIS methodology. Arch Ophthalmol. .In press.
Gardiner SK, Crabb DP. Examination of different pointwise linear regression methods for determining visual field progression. Invest Ophthalmol Vis Sci
. 2002;43:1400–1407.
[PubMed]Noureddin BN, Poinoosawmy D, Fietzke FW, Hitchings RA. Regression analysis of visual field progression in low tension glaucoma. Br J Ophthalmol
. 1991;75:493–495.
[CrossRef] [PubMed]Membrey WL, Poinoosawmy DP, Bunce C, Fitzke FW, Hitchings RA. Comparison of visual field progression in patients with normal pressure glaucoma between eyes with and without visual field loss that threatens fixation. Br J Ophthalmol
. 2000;84:1154–1158.
[CrossRef] [PubMed]Membrey WL, Bunce C, Poinoosawmy DP, Fitzke FW, Hitchings RA. Glaucoma surgery with or without adjunctive antiproliferatives in normal tension glaucoma: 2 Visual field progression. Br J Ophthalmol
. 2001;85:696–701.
[CrossRef] [PubMed]McNaught AI, Crabb DP, Fitzke FW, Hitchings RA. Modelling series of visual fields to detect progression in normal-tension glaucoma. Graefes Arch Clin Exp Ophthalmol
. 1995;233:750–755.
[CrossRef] [PubMed]Holmin C, Krakau CE. Regression analysis of the central visual field in chronic glaucoma cases: a follow-up study using automatic perimetry. Acta Ophthalmol (Copenh)
. 1982;60:267–274.
[PubMed]Krakau C. A statistical trap in the evaluation of visual field decay. Acta Ophthalmologica Suppl. 1985;173:19–21.
Spry PG, Bates AB, Johnson CA, Chauhan BC. Simulation of longitudinal threshold visual field data. Invest Ophthalmol Vis Sci
. 2000;41:2192–2200.
[PubMed]